183 results on '"Jux, Christian"'
Search Results
2. Cardiomyocyte hyperplasia and immaturity but not hypertrophy are characteristic features of patients with RASopathies
3. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease
4. Histopathology of congestive nephropathy: a case description and literature review.
5. Natural history of pulmonary atresia with intact ventricular septum (PAIVS) and critical pulmonary stenosis (CPS) and prediction of outcome
6. The p.Ala2430Val mutation in filamin C causes a "hypertrophic myofibrillar cardiomyopathy"
7. Long-term outcome of perimembranous VSD closure using the Nit-Occlud® Lê VSD coil system
8. Associated Anomalies and Outcome in Patients with Prenatal Diagnosis of Aortic Arch Anomalies as Aberrant Right Subclavian Artery, Right Aortic Arch and Double Aortic Arch.
9. Neonatal myocardial infarction: substantial improvement of cardiac function after autologous bone marrow-derived cell therapy
10. Somatic Development in Children with Congenital Heart Defects
11. Genetic basis of hypertrophic cardiomyopathy in children
12. Dietary protein restriction throughout intrauterine and postnatal life results in potentially beneficial myocardial tissue remodeling in the adult mouse heart
13. Reduced Biventricular Volumes and Myocardial Dysfunction Long-term After Pediatric Heart Transplantation Assessed by CMR
14. Advances in heart failure therapy in pediatric patients with dilated cardiomyopathy
15. Left Ventricular Physiology and Ventricular-Vascular Interactions in Young Patients After Heart Transplantation.
16. Creation of a functional Potts shunt by stenting the persistent arterial duct in newborns and infants with suprasystemic pulmonary hypertension of various etiologies
17. Letter by Rupp and Jux Regarding Article, “Mechanisms of Cardiac Repair and Regeneration”
18. Genetic Screening Reveals Heterogeneous Clinical Phenotypes in Patients with Dilated Cardiomyopathy and Troponin T2 Variants.
19. Pulmonary artery banding in infants and young children with left ventricular dilated cardiomyopathy: A novel therapeutic strategy before heart transplantation
20. Inhibition of mitochondrial respiration has fundamentally different effects on proliferation, cell survival and stress response in immature versus differentiated cardiomyocyte cell lines
21. Exercise-dependent changes in ventricular–arterial coupling and aortopulmonary collateral flow in Fontan patients: a real-time CMR study.
22. Fetal Echocardiography in Predicting Postnatal Outcome in Borderline Left Ventricle.
23. Fifteen-year Single Center Experience with the “Giessen Hybrid” Approach for Hypoplastic Left Heart and Variants: Current Strategies and Outcomes
24. Somatic Development in Children with Congenital Heart Defects
25. Stenting of Native Right Ventricular Outflow Tract Obstructions in Symptomatic Infants
26. Evaluation of the Effectiveness of an Interdisciplinary Preventive Oral Hygiene Program for Children with Congenital Heart Disease
27. Beneficial Effects of Residual Right Ventricular Outflow Tract Obstruction on Right Ventricular Volume and Function in Patients After Repair of Tetralogy of Fallot
28. Tuberculosis-Associated HLH in an 8-Month-Old Infant: A Case Report and Review
29. Novel Catheter-Interventional Strategy for Intracardiac Connecting of Total Anomalous Pulmonary Venous Return in Newborns With Hypoplastic Left Heart-Syndrome Prior to Hybrid Approach
30. Aetiology and 30-Year Long-Term Outcome of Children with Cardiomyopathy Necessitating Heart Transplantation
31. Two Melodies in Concert: Transcatheter Double-Valve Replacement
32. Interventional Atrial Septal Defect Closure Using a Totally Bioresorbable Occluder Matrix: Development and Preclinical Evaluation of the BioSTAR Device
33. Fate of a Modified Fenestration of Atrial Septal Occluder Device after Transcatheter Closure of Atrial Septal Defects in Elderly Patients
34. Stent Implantation of the Arterial Duct in Newborns with a Truly Duct-Dependent Pulmonary Circulation: A Single-Center Experience with Emphasis on Aspects of the Interventional Technique
35. BioSTAR® bioabsorbable septal repair implant
36. Biocompatibility of septal defect closure devices
37. Transcatheter Closure of Perimembranous Ventricular Septal Defects Using Umbrella Devices
38. Retrograde use of the Cardioseal/Starflex occluder device
39. Single Nuclei Sequencing Reveals Novel Insights Into the Regulation of Cellular Signatures in Children With Dilated Cardiomyopathy.
40. Symptom-orientated oral hygiene for children after heart transplantation: Effectiveness of a standardized prophylactic program.
41. Histopathological Workup of an Amplatzer Atrial Septal Defect Occluder After Surgical Removal
42. Interrelationship Between Hemodynamics, Brain Volumes, and Outcome in Hypoplastic Left Heart Syndrome.
43. Fibrotic myocardial remodeling in children and adolescents after cardiac transplantation - a CMR native T1 mapping study.
44. Intracoronary bone marrow cell application for terminal heart failure in children
45. Prenatal Mechanistic Target of Rapamycin Complex 1 (m TORC1) Inhibition by Rapamycin Treatment of Pregnant Mice Causes Intrauterine Growth Restriction and Alters Postnatal Cardiac Growth, Morphology, and Function.
46. Hypoplastic Left Heart Syndrome (HLHS).
47. Cardiovascular magnetic resonance assessment of ventricular function and myocardial scarring before and early after repair of anomalous left coronary artery from the pulmonary artery.
48. Large-diameter graft-stent (Advanta V12) implantation in various locations: early results.
49. Piccolo devices in premie ductus arteriosi.
50. BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.